The correct option is D SCID
The first clinical gene therapy was done for the treatment of SCID (Severe Combined Immuno Deficiency) resulting from the deficiency of ADA (adenosine deaminase). The SCID patient has a deletion of gene for the enzyme adenosine deaminase (ADA), due to which he/she lacks functional lymphocytes and therefore, fails to fight the infecting pathogen.